86
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Neutrophil Percentage-to-Albumin Ratio and Risk of Mortality in Patients on Peritoneal Dialysis

ORCID Icon, , , , , , , & show all
Pages 6271-6281 | Received 26 Aug 2023, Accepted 05 Dec 2023, Published online: 21 Dec 2023
 

Abstract

Background

Neutrophil percentage-to-albumin ratio (NPAR), a new inflammatory marker, has been shown to be associated with poor prognosis in patients with cardiovascular disease. However, limited evidence is available for its role in peritoneal dialysis (PD) patients. Our study aimed at investigating the prognostic value of NPAR for mortality in PD patients.

Patients and Methods

This was a single center retrospective cohort study. A total of 1966 PD patients were enrolled in our study from January 2006 to December 2016 and were followed up until December 2021. Patients were stratified into tertiles according to baseline NPAR levels. The associations between NPAR levels with all-cause and cardiovascular mortality were estimated using Cox proportional hazards models. Receiver operating characteristic (ROC) analysis was performed to compare the mortality predictive values of NPAR and other known biomarkers, such as NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio), LHR (low-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio) and MLR (monocyte-to-lymphocyte ratio).

Results

During a median follow-up of 48.1 months, 503 (25.6%) patients died, in which cardiovascular disease (CVD) death dominated 50.3%. Multivariate Cox regression analysis revealed that the highest NPAR tertile was significantly associated with a higher risk of all-cause and cardiovascular mortality (HR 1.51, 95% CI 1.14–1.98; HR 1.57, 95% CI 1.07–2.31; respectively) compared with tertile 1. The AUC values of NPAR were 0.62 (95% CI 0.60–0.65, P < 0.001) for all-cause mortality and 0.61 (95% CI 0.57–0.65, P < 0.001) for cardiovascular mortality.

Conclusion

Our study showed that higher NPAR levels were independently associated with increased risk of all-cause and cardiovascular mortality in PD patients. Notably, our results demonstrated that NPAR exhibited superior predictive value for mortality compared to NLR, PLR, MLR, and LHR.

Acknowledgments

We appreciate all the nephrologists and nurses in our PD center for their cooperation.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

All authors have declared no conflicts of interest.

Additional information

Funding

This study was supported by the Guangzhou science and technology planning project (2023A04J2183), National Natural Science Foundation of China (82000677), Guangdong Basic and Applied Basic Research Foundation (2022A1515012532), Guang dong Provincial Key Laboratory of Nephrology (2020B1212060028), and NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University).